Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

UHS

Thinking About Investing in Universal Health Services (UHS)? Know This!

Shares of Health Care sector company Universal Health Services moved 0.7% today, and are now trading at a price of $158.09. The Large-Cap stock's daily volume was 35,934 compared to its average volume of 863,604. The S&P 500 index returned a 1.0% performance.

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company is based in King of Prussia and has 76,000 full time employees. Its market capitalization is $11,473,270,784. Universal Health Services currently offers its equity investors a dividend that yields 0.5% per year.

16 analysts are following Universal Health Services and have set target prices ranging from $186.41 to $280.0 per share. On average, they have given the company a rating of buy. At today's prices, UHS is trading -29.61% away from its average analyst target price of $224.59 per share.

Over the last year, UHS shares have gone down by -4.8%, which represents a difference of -6.5% when compared to the S&P 500. The stock's 52 week high is $243.25 per share and its 52 week low is $153.99. Although Universal Health Services's average free cash flow over the last 5 years has been $728.55 Million, they have been decreasing at an average rate of -1.6%. For this reason, investors may continue to shun the stock.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2024 2,067,101 943,810 1,123,291 114.07
2023 1,267,797 743,055 524,742 100.27
2022 996,023 734,001 262,022 834.59
2021 883,695 855,659 28,036 -98.28
2020 2,360,169 731,307 1,628,862 102.5
2019 1,438,469 634,095 804,374
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS